Millrace Asset Group’s Labcorp LH Stock Holding History

Millrace Asset Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,296	Closed	-$2.01M	–	66
2017 Q1	$2.01M	Buy	+16,296	New	+$1.93M	2.04%	17

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Millrace Asset Group's LH Position: Q2 2017 in Review

Millrace Asset Group sold out of Labcorp (LH) in Q2 2017, closing a stake of 16,296 shares — an estimated $2.01M sold.

Millrace Asset Group first reported a position in LH in Q1 2017 and held it in 1 quarter. The position peaked at $2.01M in Q1 2017. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

Millrace Asset Group reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
Millrace Asset Group sold 16,296 Labcorp shares in Q2 2017, an estimated $2.01M.
Millrace Asset Group first reported a position in Labcorp in Q1 2017 and held it in 1 quarter.
Millrace Asset Group's Labcorp position peaked at $2.01M in Q1 2017.
691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Millrace Asset Group's 13F filing for Q2 2017, filed 11 Aug 2017.